Still, this is not the primary pathway the virus uses. A Paxlovid resistant virus won’t suddenly have a general evolutionary advantage for growth. It’ll just be more likely to kill people.
Why would a virus that can survive Paxlovid and continue infecting people not have an evolutionary advantage in a society with widely available Paxlovid treatments?